TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
RCEL

Avita Medical Ltd

Healthcare · Medical Devices

15.70$ -6.3% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Avita Medical Ltd (RCEL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.5% of the shares are freely tradable; institutional investors hold 17.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 17.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 98.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 9.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 31Mio.

Largest Shareholders

Institutions

Institutions RCEL
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 4.31 1,333,914 -0.1 06/30/2026
BlackRock Inc 1.83 564,952 -50.1 06/30/2026
Geode Capital Management, LLC 1.10 339,822 -37.4 06/30/2026
Marshall Wace Asset Management Ltd 1.09 338,387 +543.8 06/30/2026
AQR Capital Management LLC 1.04 321,013 +240.2 06/30/2026
Morgan Stanley - Brokerage Accounts 0.65 200,462 +27.2 06/30/2026
Vanguard Fiduciary Trust Co 0.59 182,402 -5.7 06/30/2026
Goss Wealth Management LLC 0.48 148,931 +71.4 06/30/2026

Funds

Funds RCEL
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.10 958,401 +0.0 09/30/2026
Fidelity Extended Market Index 0.50 155,780 +3.3 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?